DE602005017188D1 - Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte - Google Patents

Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte

Info

Publication number
DE602005017188D1
DE602005017188D1 DE602005017188T DE602005017188T DE602005017188D1 DE 602005017188 D1 DE602005017188 D1 DE 602005017188D1 DE 602005017188 T DE602005017188 T DE 602005017188T DE 602005017188 T DE602005017188 T DE 602005017188T DE 602005017188 D1 DE602005017188 D1 DE 602005017188D1
Authority
DE
Germany
Prior art keywords
peptide
synthesis
intermediate products
fragments
peptide fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005017188T
Other languages
German (de)
English (en)
Inventor
Yeun-Kwei Han
David A Johnston
Hiralal N Khatri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602005017188D1 publication Critical patent/DE602005017188D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005017188T 2004-12-30 2005-12-22 Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte Expired - Lifetime DE602005017188D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64091104P 2004-12-30 2004-12-30
PCT/EP2005/013853 WO2006069728A1 (en) 2004-12-30 2005-12-22 Synthesis of peptide t-20 using peptide intermediate fragments

Publications (1)

Publication Number Publication Date
DE602005017188D1 true DE602005017188D1 (de) 2009-11-26

Family

ID=36025222

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017188T Expired - Lifetime DE602005017188D1 (de) 2004-12-30 2005-12-22 Synthese des peptides t-20 aus peptidfragmenten als zwischenprodukte

Country Status (12)

Country Link
US (1) US20060276624A1 (https=)
EP (1) EP1833843B1 (https=)
JP (1) JP4886702B2 (https=)
KR (1) KR101243013B1 (https=)
CN (1) CN101133077B (https=)
AT (1) ATE445636T1 (https=)
CA (1) CA2592438C (https=)
DE (1) DE602005017188D1 (https=)
ES (1) ES2332418T3 (https=)
IL (1) IL184080A (https=)
MX (1) MX2007007917A (https=)
WO (1) WO2006069728A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261475A1 (en) * 2004-02-13 2005-11-24 Harvard Medical School Solid-phase capture-release-tag methods for phosphoproteomic analyses
ES2329270T3 (es) * 2004-12-30 2009-11-24 F. Hoffmann-La Roche Ag Sintesis del peptido t-1249 utilizando fragmentos intermediarios del ipeptido.
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
BRPI0820765A2 (pt) * 2007-12-11 2015-06-16 Hoffmann La Roche Métodos para a produção de um peptídeo insulinotrópico e peptídeos
CN110372781B (zh) * 2019-07-29 2021-11-16 深圳佳肽生物科技有限公司 恩夫韦肽的制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4010560B2 (ja) * 1992-07-20 2007-11-21 ドューク ユニバーシティー Hiv複製を阻害する化合物
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5817758A (en) * 1995-06-07 1998-10-06 Terrapin Technologies, Inc. P-nitrobenzyl side-chain protection for solid-phase synthesis
CA2324348C (en) * 1998-03-23 2006-03-14 Trimeris, Inc. Methods and compositions for peptide synthesis
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
ES2329270T3 (es) * 2004-12-30 2009-11-24 F. Hoffmann-La Roche Ag Sintesis del peptido t-1249 utilizando fragmentos intermediarios del ipeptido.

Also Published As

Publication number Publication date
KR101243013B1 (ko) 2013-03-14
MX2007007917A (es) 2007-08-14
WO2006069728A1 (en) 2006-07-06
IL184080A (en) 2010-12-30
US20060276624A1 (en) 2006-12-07
KR20070103400A (ko) 2007-10-23
EP1833843B1 (en) 2009-10-14
CA2592438A1 (en) 2006-07-06
EP1833843A1 (en) 2007-09-19
ATE445636T1 (de) 2009-10-15
JP4886702B2 (ja) 2012-02-29
IL184080A0 (en) 2007-10-31
CN101133077A (zh) 2008-02-27
CA2592438C (en) 2013-09-03
ES2332418T3 (es) 2010-02-04
CN101133077B (zh) 2012-09-05
JP2008526698A (ja) 2008-07-24

Similar Documents

Publication Publication Date Title
TW200716557A (en) Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
WO2006027705A3 (en) Synthesis of triethylenetetramines
MY151036A (en) Synthesis of (r)-n-methylnaltrexone
MX2010003599A (es) Intermediarios y metodos para la sintesis de analogos de halicondrina b.
MXPA06010097A (es) Inhibidores de dipeptidil peptidasa-iv.
MX2007013632A (es) Procedimientos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo y sus productos intermedios.
ATE507235T1 (de) Synthese von glucagon-ähnlichen peptiden
ATE492559T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
EA200801571A1 (ru) Композиции, содержащие молекулы ctl4-ig, и способы их получения
IL184080A0 (en) Synthesis of peptide t-20 using peptide intermediate fragments
WO2007103739A3 (en) Methods and compositions related to cyclic peptide synthesis
TW200640914A (en) Novel processes for the preparation of a benzofuran
IL184081A0 (en) Synthesis using peptide intermediate fragments iii
MX2007013400A (es) Metodo de sintesis de peptidos.
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
ATE439371T1 (de) Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten
DE602006021327D1 (de) Isochinoline als igf-1r-inhibitoren
DE60329721D1 (de) Regiospezifische synthese von nikotinderivaten
FR2864830B1 (fr) Procede de synthese sur support solide de composes peptidiques, notamment de composes peptidiques comportant un residu arginine
IL199752A0 (en) Purification of taci-fc
DE602006008751D1 (de) Synthese von proteaseinhibitorvorstufen
ITMI20040582A1 (it) Processo per la semisintesi di deserpidina
GB0716578D0 (en) Convergent solid phase peptide synthesis by reaction of two fragments bound to solid support
ATE496061T1 (de) Festphasenpeptidsynthese

Legal Events

Date Code Title Description
8364 No opposition during term of opposition